Sign in

CIK 0001348362

  • Non-accelerated filer
  • Smaller reporting company

Lexaria Bioscience Corp.

Sign in to watch
Ticker
LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Aug 31
Incorporated
NV
Entity type
Operating
EIN
202000871
Phone
+1 250-765-6424
Business address
100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
Former names
Lexaria Corp., LEXARIA CORP.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-10-14 Downey Gregory Chief Financial Officer Purchase +121 $2.09 $253 1,954
2022-10-14 Downey Gregory Chief Financial Officer Grant or award +121 $2.09 $253 1,954
2022-08-29 Downey Gregory Chief Financial Officer Grant or award · Stock Options +11,000 46,000
2021-09-01 Downey Gregory Chief Financial Officer Grant or award · Stock Options +10,000 35,000
2021-06-08 Downey Gregory Chief Financial Officer Grant or award · Stock Options +8,000 25,000
2021-05-07 Downey Gregory Chief Financial Officer Other disposition · Stock Options −8,000 17,000
2021-04-26 Downey Gregory Chief Financial Officer Grant or award · Stock Options +5,000 25,000

Page 1 of 1 · 7 trades